Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Furix

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    14/11/2025 Amsal Chem Private Ltd.
    India
    		 M/s Amsal Chem Pvt Ltd WC-0172 Furosemide BP/USP/EP 2025-11-11 2028-07-02 A1/401, 402, 403, G.I.D.C., At & Post - Ankleshwar, Dist. - Bharuch, Gujarat, India
    19/09/2025 Ipca Laboratories
    India
    		 M/s IPCA Laboratories Ltd WC-0091 Furosemide BP/Ph.Eur./JP/USP 2025-06-19 2028-07-02 P.O. Sejavta, District -Ratlam, (M.P.)-457001, India